Targeting TIGIT Inhibits Bladder Cancer Metastasis Through Suppressing IL-32
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting TIGIT Inhibits Bladder Cancer Metastasis Through Suppressing IL-32
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2022-01-05
DOI
10.3389/fphar.2021.801493
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Neoantigen: A New Breakthrough in Tumor Immunotherapy
- (2021) Zheying Zhang et al. Frontiers in Immunology
- The circular RNA circSPARC enhances the migration and proliferation of colorectal cancer by regulating the JAK/STAT pathway
- (2021) Jiaqi Wang et al. Molecular Cancer
- Targeted Glucose or Glutamine Metabolic Therapy Combined With PD-1/PD-L1 Checkpoint Blockade Immunotherapy for the Treatment of Tumors - Mechanisms and Strategies
- (2021) Guofeng Ma et al. Frontiers in Oncology
- Liver transcriptomics highlights interleukin-32 as novel NAFLD-related cytokine and candidate biomarker
- (2020) Guido Alessandro Baselli et al. GUT
- Molecular interactions and functions of IL‐32
- (2020) Kristin Roseth Aass et al. JOURNAL OF LEUKOCYTE BIOLOGY
- TIGIT in cancer immunotherapy
- (2020) Joe-Marc Chauvin et al. Journal for ImmunoTherapy of Cancer
- Local and Systemic Interleukin-32 in Esophageal, Gastric, and Colorectal Cancers: Clinical and Diagnostic Significance
- (2020) Dorota Diakowska et al. Diagnostics
- TOX-expressing terminally exhausted tumor-infiltrating CD8+ T cells are reinvigorated by co-blockade of PD-1 and TIGIT in bladder cancer
- (2020) Hye Sook Han et al. CANCER LETTERS
- CD4+ TSCMs in the Bone Marrow Assist in Maturation of Antibodies against Influenza in Mice
- (2019) Kang Wu et al. MEDIATORS OF INFLAMMATION
- Regulatory T cells in cancer immunosuppression — implications for anticancer therapy
- (2019) Yosuke Togashi et al. Nature Reviews Clinical Oncology
- Preferential Homing of Tumor-specific and Functional CD8+ Stem Cell-like Memory T Cells to the Bone Marrow
- (2019) Kang Wu et al. JOURNAL OF IMMUNOTHERAPY
- Advances in cancer immunotherapy 2019 – latest trends
- (2019) Stephan Kruger et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Tumor-associated macrophages in tumor metastasis: biological roles and clinical therapeutic applications
- (2019) Yuxin Lin et al. Journal of Hematology & Oncology
- IL-32γ suppresses lung cancer stem cell growth via inhibition of ITGAV-mediated STAT5 pathway
- (2019) Yong Sun Lee et al. Cell Death & Disease
- TIGIT as an emerging immune checkpoint
- (2019) H. Harjunpää et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- OUP accepted manuscript
- (2018) BIOINFORMATICS
- Preclinical Data Supporting Antitumor Activity of PD-1 Blockade
- (2018) Michael A. Curran CANCER JOURNAL
- Insights into the role of IL-32 in cancer
- (2018) Yvette J.E. Sloot et al. SEMINARS IN IMMUNOLOGY
- Development of immunotherapy in bladder cancer: present and future on targeting PD(L)1 and CTLA-4 pathways
- (2018) Mathieu Rouanne et al. WORLD JOURNAL OF UROLOGY
- IL-32 gamma reduces lung tumor development through upregulation of TIMP-3 overexpression and hypomethylation
- (2018) Jaesuk Yun et al. Cell Death & Disease
- Allele-specific long-distance regulation dictates IL-32 isoform switching and mediates susceptibility to HIV-1
- (2018) Robert-Jan Palstra et al. Science Advances
- Role of IL-32 Gamma on Bone Metabolism in Autoimmune Arthritis
- (2018) Oh Chan Kwon et al. Immune Network
- TIGIT: a novel immunotherapy target moving from bench to bedside
- (2018) Benjamin L. Solomon et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Cancer-associated fibroblast (CAF)-derived IL32 promotes breast cancer cell invasion and metastasis via integrin β3–p38 MAPK signalling
- (2018) Siyang Wen et al. CANCER LETTERS
- UMI-tools: modeling sequencing errors in Unique Molecular Identifiers to improve quantification accuracy
- (2017) Tom Smith et al. GENOME RESEARCH
- GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses
- (2017) Zefang Tang et al. NUCLEIC ACIDS RESEARCH
- Interleukin 32, inflammation and cancer
- (2017) Jin Tae Hong et al. PHARMACOLOGY & THERAPEUTICS
- TIGIT: A Key Inhibitor of the Cancer Immunity Cycle
- (2017) Nicholas A. Manieri et al. TRENDS IN IMMUNOLOGY
- IL-32: A Novel Pluripotent Inflammatory Interleukin, towards Gastric Inflammation, Gastric Cancer, and Chronic Rhino Sinusitis
- (2016) Muhammad Babar Khawar et al. MEDIATORS OF INFLAMMATION
- Dysregulation of over-expressed IL-32 in colorectal cancer induces metastasis
- (2015) Yi Yang et al. World Journal of Surgical Oncology
- Interleukin-32 Increases Human Gastric Cancer Cell Invasion Associated with Tumor Progression and Metastasis
- (2014) C.-Y. Tsai et al. CLINICAL CANCER RESEARCH
- Interleukin-32 in Inflammatory Autoimmune Diseases
- (2014) Soohyun Kim Immune Network
- STAR: ultrafast universal RNA-seq aligner
- (2012) Alexander Dobin et al. BIOINFORMATICS
- Activation of the interleukin-32 pro-inflammatory pathway in response to human papillomavirus infection and over-expressionof interleukin-32 controls the expression of the humanpapillomavirus oncogene
- (2011) Sojung Lee et al. IMMUNOLOGY
- Interleukin-32 enhances cytotoxic effect of natural killer cells to cancer cells via activation of death receptor 3
- (2011) Mi H. Park et al. IMMUNOLOGY
- IL-32γ inhibits cancer cell growth through inactivation of NF-κB and STAT3 signals
- (2011) J H Oh et al. ONCOGENE
- Expression of IL-32 in Human Lung Cancer Is Related to the Histotype and Metastatic Phenotype
- (2009) Carlo Sorrentino et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Interleukin-32 Expression in the Pancreas
- (2009) Atsushi Nishida et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Interleukin-32 induces the differentiation of monocytes into macrophage-like cells
- (2008) M. G. Netea et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now